Sat.May 13, 2023 - Fri.May 19, 2023

article thumbnail

Avoid These Independent Pharmacy Marketing Pitfalls

Drug Topics

Marketing costs money, so be sure to spend wisely.

article thumbnail

PBMs Face Criticism From Many Angles

Drug Topics

The National Community Pharmacists Association now has plenty of allies in its fight with the pharmacy benefit managers.

187
187
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

There Are Food, Drug Interactions Older Adults Should Be Aware Of As They Age

Pharmacy Times

Good practice for older adults is that calories should go down while nutrient intake goes up as they age.

123
123
article thumbnail

ICYMI: PhRMA CMO Dr. Michael Ybarra speaks with Dr. Fabian Sandoval about clinical trial diversity

PhRMA

Enhancing clinical trial diversity is a challenge, but with a multi-faceted, community-centered approach, we can help underrepresented patients be more involved in the research and development of potential life-saving medical treatments.

162
162
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Krystal's Vyjuvek becomes first topical gene therapy with FDA nod to treat rare skin disease

Fierce Pharma

Krystal's Vyjuvek becomes first topical gene therapy with FDA nod to treat rare skin disease zbecker Fri, 05/19/2023 - 16:25

FDA 145
article thumbnail

Are We Close To A Universal Flu Vaccine?

Drug Topics

Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.

Vaccines 198

More Trending

article thumbnail

Lipid Nanoparticles Could Be Effective Carriers for mRNA Vaccines for Viral Lung Infections

Pharmacy Times

Nanoparticles could improve the solubility of drugs, aid in treatment escape from the immune system, and increase the half-life of drugs in the circulatory system against viral lung infections such as influenza, coronavirus, and respiratory syncytial virus.

article thumbnail

Kaiser Permanente discloses timeline, financial commitments for its VBC megadeal with Geisinger Health

Fierce Healthcare

Kaiser Permanente discloses timeline, financial commitments for its VBC megadeal with Geisinger Health dmuoio Tue, 05/16/2023 - 12:40

138
138
article thumbnail

News Roundup: May 15 to May 19

Drug Topics

Your weekly roundup of the latest news from Drug Topics®.

187
187
article thumbnail

STAT+: In its first tough test, CRISPR epigenome editing cuts cholesterol levels in monkeys

STAT

A defanged form of CRISPR, which doesn’t slice or nick DNA, but rather alters the epigenome — the layers of chemical coding that sit on top of DNA and control the activity of genes — has aced its first substantive test. When researchers used CRISPR “ epigenome editing ” to dial down a cholesterol-associated gene in monkeys, the animals’ blood levels of heart-disease-causing LDL, or “bad” cholesterol, plummeted by more than 50%, Jennifer Kwo

144
144
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Older Adults Hospitalized With Heart Failure Are More Likely To Experience Frailty

Pharmacy Times

Diagnosing risk of frailty in patients hospitalized with heart failure is a safe and effective means of improving patient management.

Hospitals 139
article thumbnail

PBGH: What employers want to see as Congress aims to reform PBMs

Fierce Healthcare

PBGH: What employers want to see as Congress aims to reform PBMs pminemyer Mon, 05/15/2023 - 16:13

138
138
article thumbnail

Medical Cannabis Associated With Improvements in Health-Related Quality of Life

Drug Topics

Balanced products showed greater improvements compared to either CBD-dominant or THC-dominant products.

187
187
article thumbnail

Study: Giving an antibiotic to household contacts of people with leprosy slashes chances of spread

STAT

When someone has leprosy, people who live in the same household face the highest odds of contracting the infection. But in a new trial, providing those contacts with a single dose of an antibiotic typically used to treat tuberculosis drastically reduced that risk, researchers reported Wednesday. The trial, which took place in China, corroborates the idea of giving close contacts an antibiotic as a way to reduce the likelihood that the disease spreads, experts said.

143
143
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Novavax’s COVID-Influenza Combination Vaccine Demonstrates Reassuring Preliminary Safety Profile

Pharmacy Times

Investigators of the phase 2 study also found a comparable reactogenicity to the individual influenza and COVID-19 vaccines from Novavax or authorized vaccine comparators.

Vaccines 139
article thumbnail

Cybersecurity attack against Amazon-owned online pharmacy PillPack exposed user health data

Fierce Healthcare

Cybersecurity attack against Amazon-owned online pharmacy PillPack exposed user health data aburky Fri, 05/19/2023 - 16:16

137
137
article thumbnail

Activity “Snacking” Can Benefit Individuals With T1D

Drug Topics

Doing small spurts of exercise throughout the day provide numerous benefits.

187
187
article thumbnail

After decades of neglecting women athletes, sport and exercise medicine is finally catching up

STAT

When cyclist Alison Tetrick joined the sport’s professional ranks, she received the perks that come with the job — new bikes and clothing included. But she could never get comfortable on the bike saddles. After several years, Tetrick suffered so much damage to her genital area that she eventually resorted to surgery to trim excess skin from her labia.

143
143
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Intercept's NASH dreams may be dashed after FDA panel votes against Ocaliva's approval bid

Fierce Pharma

Intercept's NASH dreams may be dashed after FDA panel votes against Ocaliva's approval bid fkansteiner Fri, 05/19/2023 - 17:30

FDA 134
article thumbnail

FTC expands probe into pharmacy benefit managers to GPOs

Fierce Healthcare

FTC expands probe into pharmacy benefit managers to GPOs pminemyer Wed, 05/17/2023 - 16:36

135
135
article thumbnail

US FDA approves Bausch + Lomb and Novaliq’s DED treatment Miebo

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval to Bausch + Lomb and Novaliq’s Miebo (perfluorohexyloctane ophthalmic solution) to treat the signs and symptoms of dry eye disease (DED). Formerly known as NOV03, Miebo is a first-in-class eye drop designed for preventing the evaporation of excessive tears and restoring tear balance in evaporative DED patients.

FDA 133
article thumbnail

STAT+: Pear Therapeutics sold for parts at $6 million auction

STAT

Four different companies agreed to buy the assets of Pear Therapeutics at auction on Thursday morning after the digital health company filed for bankruptcy last month. Click Therapeutics, Welt Corp, Harvest Bio, and Nox Health Group each acquired bits of the company for $6.05 million, far short of the $32 million in debt Pear carried. A hearing to approve the sale will be held on May 22.

FDA 136
article thumbnail

Bausch + Lomb bags FDA approval for dry eye disease treatment Miebo

Fierce Pharma

Bausch + Lomb bags FDA approval for dry eye disease treatment Miebo zbecker Fri, 05/19/2023 - 09:39

FDA 133
article thumbnail

Commercial payers frequently delayed paying out providers' claims in Q1, report finds

Fierce Healthcare

Commercial payers frequently delayed paying out providers' claims in Q1, report finds dmuoio Fri, 05/19/2023 - 15:44

133
133
article thumbnail

Challenges in Reimbursement for Pharmacy Services, DIR Fees, and the Evolving PBM Model

Pharmacy Times

Amid various obstacles, health care providers and pharmacists can initiate measures to enhance compensation for pharmacy services in managed care.

132
132
article thumbnail

STAT+: Biden drug czar to summon naloxone makers to White House to discuss pricing

STAT

WASHINGTON — The White House is summoning naloxone manufacturers for a roundtable focused on the medication’s price, the Biden administration’s top drug policy official told STAT. The move would represent the White House’s most concrete action to date to address the price of naloxone , a medication used to reverse opioid overdoses.

136
136
article thumbnail

Regulatory tracker: Another China-made PD-1 starts FDA journey as Elevar, Hengrui target big cancer type

Fierce Pharma

Regulatory tracker: Another China-made PD-1 starts FDA journey as Elevar, Hengrui target big cancer type aliu Wed, 05/17/2023 - 09:41

FDA 133
article thumbnail

Industry Voices—The case for hospitals to invest in cleaner air

Fierce Healthcare

Industry Voices—The case for hospitals to invest in cleaner air pminemyer Sun, 05/14/2023 - 23:25

Hospitals 131
article thumbnail

FDA Approves Perfluorohexyloctane Ophthalmic Solution for Dry Eye Disease

Pharmacy Times

The approval marks the first and only FDA-approved treatment for dry eye disease that directly targets tear evaporation.

FDA 132
article thumbnail

3 things about the PhRMA Foundation

PhRMA

To achieve a healthier world where all people have access to life-changing medicines, we must support researchers working to advance biopharmaceutical innovation and value-driven health care. This is the purpose of the PhRMA Foundation, a 58-year-old nonprofit that catalyzes the careers of promising researchers through competitive, peer-reviewed grants and fellowships.

130
130
article thumbnail

Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?

Fierce Pharma

Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?

131
131
article thumbnail

5 Things I Love About The MAD-ID Conference, The Antimicrobial Stewardship Meeting

IDStewardship

In this article an infectious diseases pharmacists discusses the MAD-ID conference, which is known as The Antimicrobial Stewardship Meeting, Making A Difference In Infectious Diseases (MAD-ID). Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 14 May 2023 People practicing in the area of infectious diseases and antimicrobial stewardship have a lot of options for professional meetings to attend.

article thumbnail

Pegfilgrastim Biosimilar for Treatment of Neutropenia Launches

Pharmacy Times

Pegfilgrastim-pbbk is a leukocyte growth factor developed to reduce the onset of infection in patients with non-myeloid malignancies administered myelosuppressive anticancer medications associated with a clinically significant rate of febrile neutropenia.

132
132